Zephyrnet Logo

Tag: cancer treatment

Lymphatics drain nanoparticles from tumours – Nature Materials

Nanoparticle transport into and out of solid tumours is an important, translationally relevant phenomenon. Harnessing the characteristics of the remodelled tumour vasculature has led...

The Cannabis Cancer Connection | Project CBD

Adapted from The Cannabis Cancer Connection: How to use cannabis and hemp to kill cancer cells by Joe D. Goldstrich, MD, with Angela Bacca (Flower...

Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference...

50,000 or 100,000 ppm UNO alone or in combination with anti-mCTLA-4 more than tripled antigen specific central memory T-cell response versus anti-mCTLA-4 alone...

Exploring the Medical Implications and Uses of HHC: Unveiling its Therapeutic Potential

Exploring the Medical Implications and Uses of HHC: Unveiling its Therapeutic PotentialIn recent years, there has been a growing interest in exploring the medical...

AstraZeneca and Daiichi’s next cancer medicine scores in breast tumors

Dive Brief: A new cancer drug developed by Daiichi Sankyo and AstraZeneca met one of its two main goals in a breast cancer trial, helping...

Engineered Bacteria Can Detect Tumor DNA

September 20, 2023, by Elia Ben-Ari A team of US and Australian scientists has...

Catching up with 2023 SOCRA President’s Award Winner Tammy Neseth, MA, CCRP, CIP – SOCRA Blog

Tammy Neseth, MA, CCRP, CIP The global clinical research community will converge live and in-person from September 29 – October 1 at SOCRA’s 2023...

CIRM Joins #GoGold Childhood Cancer Awareness Campaign

CIRM has also invested $8.4 million to support a Phase 1 clinical trial at City of Hope targeting malignant brain tumors in children....

Aflac, Hitachi, and GlobalLogic Collaborate to Create an Ecosystem to Support Employees with Cancer

TOKYO, Sep 12, 2023 - (JCN Newswire) - Aflac Life Insurance Japan Ltd. ("Aflac"), Hitachi, Ltd. ("Hitachi"), and GlobalLogic Japan, Ltd. ("GlobalLogic")(1) start full-scale...

AI has the potential to make smartwatches a user’s definitive health copilot

<!-- --> Utilised correctly, AI has the potential to make smartwatches a user’s health copilot thanks to its...

FDA approval for Janssen’s prostate cancer treatment

The US FDA approval of Akeega (niraparib and abiraterone acetate) is based on positive results from the Phase III MAGNITUDE study. The US Food and...

NCI’s CPTAC releases new proteogenomic dataset

What The National Institutes of Health is releasing a comprehensive dataset that standardizes genomic, proteomic, imaging,...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?